BridgeMD
New treatment option for Type 1 Diabetes (T1D)
Official title Circadian Mechanisms, Glucose, and CV Risks in T1D
ClinicalTrials.gov ID: NCT06624046
What this study is testing
- What it's testing
- People with type 1 diabetes are disproportionately affected by cardiovascular disease (CVD). Short and irregular sleep have been associated with cardiovascular risk in this population.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Adults 18-50 years with a clinical diagnosis of T1D for at least one year
- Report habitual sleep irregularity ≥1 hour/week
- Desire to improve sleep, and own a smartphone (Android or iPhone)
You likely can't join if
- Self-reported A1C within the past 6 months ≥10%
- insomnia symptoms defined as Insomnia Severity Index score ≥15
- history of restless leg syndrome
- history of severe hypoglycemia (defined as hypoglycemic episode that results in loss of consciousness, seizure, or requiring emergency room visit or...
- rotating shift or night work or routinely sleeping after 3 AM.
- use of sleep medications/aids, significant medical comorbidities (such as heart failure, cirrhosis, chronic obstructive pulmonary disease requiring...
See the full eligibility criteria
- Adults 18-50 years with a clinical diagnosis of T1D for at least one year
- Report habitual sleep irregularity ≥1 hour/week
- Desire to improve sleep, and own a smartphone (Android or iPhone)
- Self-reported A1C within the past 6 months ≥10%
- insomnia symptoms defined as Insomnia Severity Index score ≥15
- history of restless leg syndrome
- history of severe hypoglycemia (defined as hypoglycemic episode that results in loss of consciousness, seizure, or requiring emergency room visit or hospitalization) within the past 6 months
- rotating shift or night work or routinely sleeping after 3 AM.
- use of sleep medications/aids, significant medical comorbidities (such as heart failure, cirrhosis, chronic obstructive pulmonary disease requiring oxygen, active treatment for cancer, on renal replacement therapy...
- depression (Patient Health Questionnaire 8 [PHQ-8] score ≥15)
- history of stroke with neurological deficits
- pregnant, breast feeding, or planning pregnancy, as sleep and glucose are known to change during pregnancy and breastfeeding.
- Allergy to lidocaine Participants who passed the first screen by phone will be scheduled for a consenting visit at UIC
The study team makes the final eligibility decision.
Where it's taking place
- Chicago, Illinois, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chicago, Illinois, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.